Patent Assignment
Reel/Frame 020930/0905
Address Change
Recorded: 2008-05-13
Pages: 9
Assignor
IMMUNOGEN, INC.
Executed: 2008-03-24
Assignee
IMMUNOGEN, INC.
830 WINTER STREET, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(72)
Blocked Lectins, Methods and Affinity Support for Making Same Using Affinity Ligands, and Method of Killing Selected Cell Populations Having Reduced Nonselective Cytotoxicity
Patent:
5,239,062 →
Application:
07/560,948 →
Cytotoxic Agents Comprising Maytansinoids and Their Therapeutic Use
Patent:
5,208,020 →
Application:
07/911,380 →
Resurfacing of Rodent Antibodies
Patent:
5,639,641 →
Application:
07/942,245 →
Cytotoxic Agents Comprising Maytansinoids and Their Therapeutic Use
Patent:
5,416,064 →
Application:
07/986,578 →
Blocked Lectins; Methods and Affinity Support for Making the Same Using Affinity Ligands; and Method of Killing Selected Cell Populations Having Reduced Non-Selective Cytotoxicity
Patent:
5,395,924 →
Application:
08/019,831 →
Cell Binding Agent Conjugates of Analogues and Derivatives of Cc-1065
Patent:
5,475,092 →
Application:
08/210,742 →
Targeted Delivery of Cyclopropylbenzinddole-Containing Cytotoxic Drugs
Patent:
5,846,545 →
Application:
08/468,306 →
Cyclopropylbenzimdoe-Containing Cytotoxic Drugs
Patent:
5,585,499 →
Application:
08/469,891 →
Compounds and Methods for Regulating Apoptosis, and Methods of Making and Screening for Compounds That Regulate Apoptosis
Patent:
7,193,044 →
Application:
09/580,523 →
Process for the preparation and purification of thiol-containing maytansinoids
Patent:
6,333,410 →
Application:
09/641,348 →
Compositions and Methods for Treating Cancer Using Immunoconjugates and Chemotherapeutic Agents
Patent:
7,303,749 →
Application:
09/671,995 →
Cytotoxic agents comprising taxanes and their therapeutic use
Patent:
6,340,701 →
Application:
09/717,026 →
Cytotoxic Agents Comprising Modified Doxorubicins and Daunorubicins and Their Therapeutic Use
Methods for Preparation of Cytotoxic Conjugates of Maytansinoids and Cell Binding Agents
Patent:
6,441,163 →
Application:
09/867,598 →
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
BBC3 Gene Promoter and Methods for Identifying Modulators of Apoptosis and BBC3 Gene Expression Using a BBC3 Gene Promoter
Cytotoxic Agents Bearing a Reactive Polyethylene Glycol Moiety, Cytotoxic Conjugates Comprising Polyethylene Glycol Linking Groups, and Methods of Making and Using the Same
Mutant Actinosynnema Pretiosum Strain with Increased Maytansinoid Production
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
Cc-1065 Analog Synthesis
Patent:
6,534,660 →
Application:
10/116,052 →
Prodrugs of Cc-1065 Analogs
Cytotoxic Agents Comprising Polyethylene Glycol-Containing Taxanes and Their Therapeutic Use
Patent:
6,596,757 →
Application:
10/144,042 →
Methods for Preparation of Cytotoxic Conjugates of Maytansinoids and Cell Binding Agents
Anti-Igf-I Receptor Antibody
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
Cc-1065 Analog Synthesis
Patent:
6,586,618 →
Application:
10/265,329 →
Cc-1065 Analog Synthesis
Cytotoxic Agents Containing Novel Potent Taxanes and Their Therapeutic Use
Process for the Preparation and Purification of Thiol-Containing Maytansinoids
Patent:
39,151 →
Application:
10/410,143 →
Antibodies to Non-Shed MUC1 and MUC16, and Uses Thereof
Cross-Linkers with High Reactivity and Solubility and Their Use in the Preparation of Conjugates for Targeted Delivery of Small Molecule Drugs
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
Prodrugs of Cc-1065 Analogs
Anti-CD33 Antibodies and Method for Treatment of Acute Myeloid Leukemia Using the Same
Anti-Igf-I Receptor Antibody
Cytotoxic Agents Comprising New Maytansinoids
Mutant Actinosynnema Pretiosum Strain with Increased Maytansinoid Production
Cytotoxic Agents Containing Novel Potent Taxanes and Their Therapeutic Use
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates, and Methods of Making Said Conjugates
Cytotoxic Agents Containing Novel Potent Taxanes and Their Therapeutic Use
Methods for the Production of Ansamitocins
Compounds, Methods of Screening, and in Vitro and in Vivo Uses Involving Anti-Apoptotic Genes and Anti-Apoptotic Gene Products
Facile Method for Synthesizing Baccatin Iii Compounds
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
CA6 Antigen-Specific Cytotoxic Conjugate and Methods of Using the Same
Prodrugs of Cc-1065 Analogs
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
Method for the Preparation of Maytansinoid Esters
Anti-CD33 Antibodies and Method for Treatment of Acute Myeloid Leukemia Using the Same
Elimination of heterogeneous or mixed cell population in tumors
Application:
11/404,001 →
Publication:
US 2006/0233814
Compositions and Methods for Treating Cancer Using Immunoconjugates and Chemotherapeutic Agents
Immunoconjugate formulations
Method of Acylating Maytansinol with Chiral Amino Acids
Process for Preparation of Maytansinol
Prodrugs of Cc-1065 Analogs
Cytotoxic Agents Comprising New C-2 Modified Taxanes
Cytotoxic Agents Comprising New Maytansinoids
Cytotoxic Agents Comprising New Maytansinoids
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
Grouping writing regions of digital ink
Cytotoxic Agents Comprising Taxanes and Their Therapeutic Use
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Methods for Improving Antibody Production
Application:
11/929,334 →
Publication:
US 2008/0138898
Anti-CD33 Antibodies and Method for Treatment of Acute Myeloid Leukemia Using the Same
Application:
11/961,256 →
Publication:
US 2008/0167458
CA6 Antigen-Specific Cytotoxic Conjugate and Methods of Using the Same
Elimination of heterogeneous or mixed cell polulation in tumors
Application:
60/781,722 →
Methods for improving antibody production
Application:
60/855,361 →
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Jan 8, 1991
From: BLATTLER, WALTER A.; GOLDMACHER, VICTOR S.; CHARI, RAVI V.J.; SCOTT, CHARLES F., JR.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 005584/0097 →
Assignment of Assignors Interest.
Jan 8, 1991
From: MORONEY, SIMON E.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 005584/0095 →
Assignment of Assignor's Interest
Apr 15, 1994
From: ROGUSKA, MICHAEL A.; GUILD, BRAYDON C.
To: IMMUNOGEN, INC.
Reel/Frame 006946/0019 →
Assignment of Assignor's Interest
Apr 15, 1994
From: UNIVERSITY OF BATH, THE
To: IMMUNOGEN, INC.
Reel/Frame 006946/0017 →
Assignment of Assignor's Interest
Apr 15, 1994
From: PEDERSEN, JAN T.; SEARLE, STEPHEN M.J.; REES, ANTHONY R.
To: UNIVERSITY OF BATH
Reel/Frame 006946/0015 →
Assignment of Assignor's Interest
Aug 18, 2000
From: CHARI, RAVI VANKEEPURAM JAGANNATHA; WIDDISON, WAYNE CHARLES
To: IMMUNOGEN, INC.
Reel/Frame 011054/0816 →
Assignment of Assignor's Interest
Dec 5, 2000
From: CHARI, RAVI V.J.
To: IMMUNOGEN, INC.
Reel/Frame 011386/0756 →
Assignment of Assignor's Interest
Mar 27, 2001
From: CHARI, RAVI V.J.; BLATTLER, WALTER A.
To: IMMUNOGEN INC.
Reel/Frame 011609/0468 →
Assignment of Assignor's Interest
Aug 21, 2001
From: CHARI, RAVI V.J.; BLATTER, WALTER A.
To: IMMUNOGEN INC.
Reel/Frame 012105/0934 →
Assignment of Assignor's Interest
Aug 21, 2001
From: CHARI, RAVI; BLATTLER, WALTER
To: IMMUNOGEN INC.
Reel/Frame 012089/0637 →
Assignment of Assignor's Interest
Sep 17, 2001
From: HAN, JIA-WEN; CHITTENDEN, THOMAS
To: IMMUNOGEN INC.
Reel/Frame 012180/0332 →
Assignment of Assignor's Interest
Sep 28, 2001
From: CHARI, RAVI V.J.; WIDDISON, WAYNE C.
To: IMMUNOGEN, INC.
Reel/Frame 012210/0589 →
Assignment of Assignor's Interest
Dec 21, 2001
From: ZHAO, ROBERT YONGXIN; MILLER, MICHAEL LOUIS; WIDDISON, WAYNE CHARLES; CHARI, RAVI V.J.
To: IMMUNOGEN, INC.
Reel/Frame 012402/0662 →
Assignment of Assignor's Interest
May 28, 2002
From: CHUNG, JOHNSON; BYNG, GRAHAM S.
To: IMMUNOGEN INC.
Reel/Frame 012938/0891 →
Assignment of Assignor's Interest
Jul 3, 2002
From: ZHAO, ROBERT YONGXIN; CHARI, RAVI V.J.
To: IMMUNOGEN INC.
Reel/Frame 013055/0842 →
Assignment of Assignor's Interest
Jul 17, 2002
From: ZHAO, ROBERT YONGXIN; CHARI, RAVI V.J.
To: IMMUNOGEN INC.
Reel/Frame 013098/0068 →
Assignment of Assignor's Interest
Aug 9, 2002
From: CHARI, RAVI V.J.; MILLER, MICHAEL LOUIS
To: IMMUNOGEN INC.
Reel/Frame 013195/0909 →
Assignment of Assignor's Interest
Jun 17, 2004
From: IMMUNOGEN, INC.
To: GENENTECH, INC.
Reel/Frame 015471/0139 →
Merger
Nov 9, 2006
From: APOPTOSIS TECHNOLOGY, INC.
To: IMMUNOGEN, INC.
Reel/Frame 018499/0671 →
Corrective Assignment to Correct the the Assignee Address Needs to Be Updated. Please Change the State from Maryland to Massachusetts. Previously Recorded on Reel 018499 Frame 0671. Assignor(S) Hereby Confirms the the Assignee Address Needs to Be Updated. Please Change the State from Maryland to Massachusetts..
Nov 9, 2006
From: APOPTOSIS TECHNOLOGY, INC.
To: IMMUNOGEN, INC.
Reel/Frame 018501/0685 →
Assignment of Assignor's Interest
Nov 9, 2006
From: ZHOU, XIAO-MAI
To: APOPTOSIS TECHNOLOGY, INC.
Reel/Frame 018500/0526 →
Corrective Assignment to Correct the Atty. Docket No. Previously Recorded on Reel 018501 Frame 0685. Assignor(S) Hereby Confirms the Merger (See Document for Details)..
Nov 13, 2006
From: APOPTOSIS TECHNOLOGY, INC.
To: IMMUNOGEN, INC.
Reel/Frame 018508/0307 →
Corrective Assignment to Correct the State and Atty. Docket No. Previously Recorded on Reel 018500 Frame 0526. Assignor(S) Hereby Confirms the Assignment of Assignors Interest (See Documetn for Details).
Nov 17, 2006
From: ZHOU, XIAO-MAI
To: APOPTOSIS TECHNOLOGY, INC.
Reel/Frame 018534/0451 →